Hong Kong pharmaceutical stocks strengthened, Wuxi Biologics surged more than 7%.

As of the deadline for submission, Rongchang Biological increased by 9.38%, Jishiyao Pharmaceutical-B increased by 6.66%, and Pharmaron increased by 6.32%.